{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-02-14T12:27:01.162114+00:00",
  "news": [
    {
      "title": "Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5\" target=\"_blank\">Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-13T17:02:15+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTFVZckJnZjVUN0VKeHJ5QmVSSk9JZDBVcUVlRXI5MnBVajFiWVBtR1RaR0Fyb0FMN3pxZ2FLUDFyUmFNY0MwQUxRVjFGSEFMQ0ZHcnVfT05RdTI4UUlCVjB0eHc4WmlHR1Z0b3lSNnhwdEdud19yOW92bFM3U0lCV2dEdU42SWd3X2cw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOTFVZckJnZjVUN0VKeHJ5QmVSSk9JZDBVcUVlRXI5MnBVajFiWVBtR1RaR0Fyb0FMN3pxZ2FLUDFyUmFNY0MwQUxRVjFGSEFMQ0ZHcnVfT05RdTI4UUlCVjB0eHc4WmlHR1Z0b3lSNnhwdEdud19yOW92bFM3U0lCV2dEdU42SWd3X2cw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals’s (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-12T21:11:25+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 11 Analysts - Benzinga",
      "link": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxPV2l4cC1mdHZ5cDRlcnlhWlBYZ3RKeEtINWdQNDk5QlMxdGxGZzlsWEo1dUh6ejN1dUJRQ05DaEcxSU9sWGpzNDBtTVpXWkZnQmNTM1QzU3VPeWVlMGdyVUwtNmtmRWJRNWZKWjF0Rm5rRFN3d0N3VDh4QWNrR2ZJQTRuSjZ0RjVfZkRBNkpiUmNNX2Nic2hyMVV2VGc0cVZrRGhyaXNWZEN2d29iNEV1V1h0S3NVYnNWRG5NTEN1aDRUQ19QTDFBU29raWZkOFJ5VXQ4N2N5Z0dYNHlR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi3AFBVV95cUxPV2l4cC1mdHZ5cDRlcnlhWlBYZ3RKeEtINWdQNDk5QlMxdGxGZzlsWEo1dUh6ejN1dUJRQ05DaEcxSU9sWGpzNDBtTVpXWkZnQmNTM1QzU3VPeWVlMGdyVUwtNmtmRWJRNWZKWjF0Rm5rRFN3d0N3VDh4QWNrR2ZJQTRuSjZ0RjVfZkRBNkpiUmNNX2Nic2hyMVV2VGc0cVZrRGhyaXNWZEN2d29iNEV1V1h0S3NVYnNWRG5NTEN1aDRUQ19QTDFBU29raWZkOFJ5VXQ4N2N5Z0dYNHlR?oc=5\" target=\"_blank\">A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 11 Analysts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Benzinga</font>",
      "published": "2026-02-13T12:00:32+00:00",
      "source": "Benzinga"
    },
    {
      "title": "Vertex’s CRISPR therapy rebounds in latest earnings - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMif0FVX3lxTFB1NWEzVGlyOHUyQldlZ1B3UEQzUkUtNWpIRUlkb2tsbm9zcjlaU1JIQ2NrUk9OY2w3eDdnendtbHo0cGNTSzZsalhXWXl4a01XN3UyY0FJMUM1Snl3VnFkeW5hRVJidzNsYTRmT2FOeGJCc1pMTldESnpLbmF5ZkE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMif0FVX3lxTFB1NWEzVGlyOHUyQldlZ1B3UEQzUkUtNWpIRUlkb2tsbm9zcjlaU1JIQ2NrUk9OY2w3eDdnendtbHo0cGNTSzZsalhXWXl4a01XN3UyY0FJMUM1Snl3VnFkeW5hRVJidzNsYTRmT2FOeGJCc1pMTldESnpLbmF5ZkE?oc=5\" target=\"_blank\">Vertex’s CRISPR therapy rebounds in latest earnings</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2026-02-13T20:23:02+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPSWdlTGdYc294RWpMd0I1U3JkVHJrMkNwdVZqRzdnQnptajItZTFOTEtXNEFjUXowM2k4ZmN2c1B1YWdnZTA1d1RxNFFWeXNKVW9SUzU2V3JueU1pU3hWZURrUXNjb0FZVjd0SnhjUlZYT25BckFBOTRscTg2TS1jVWFieURGd1diS2lyUURScnlreFhiUmhPYlpyeTJaMG9XcFUycFNtVjJqVWtyWGNwOTRBeVRGMHo0dE9UeS13?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxPSWdlTGdYc294RWpMd0I1U3JkVHJrMkNwdVZqRzdnQnptajItZTFOTEtXNEFjUXowM2k4ZmN2c1B1YWdnZTA1d1RxNFFWeXNKVW9SUzU2V3JueU1pU3hWZURrUXNjb0FZVjd0SnhjUlZYT25BckFBOTRscTg2TS1jVWFieURGd1diS2lyUURScnlreFhiUmhPYlpyeTJaMG9XcFUycFNtVjJqVWtyWGNwOTRBeVRGMHo0dE9UeS13?oc=5\" target=\"_blank\">All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2026-02-13T12:58:37+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Signals Confident Growth Beyond CF - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNT0w3TjFuQzV1MFdhOE83X2c4Nnh4aHI2VXJvU1pvT0F3QVY2TWx5M1IzZmFsMV80YW9LX1VKQjBRdl90MTBRVnJoajNNaGNCRkZ1OWJONnczQTRqQjdoQVp0TUhxSmZ1LWhXSVdUSHg1c3hscVdEYkFqQzVKWlpCNlVSZk5OY3pFc2xlckVod2tWZ3pIVC1DQnBsd2FmREpReFEzRzdyME43eWlzWXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxNT0w3TjFuQzV1MFdhOE83X2c4Nnh4aHI2VXJvU1pvT0F3QVY2TWx5M1IzZmFsMV80YW9LX1VKQjBRdl90MTBRVnJoajNNaGNCRkZ1OWJONnczQTRqQjdoQVp0TUhxSmZ1LWhXSVdUSHg1c3hscVdEYkFqQzVKWlpCNlVSZk5OY3pFc2xlckVod2tWZ3pIVC1DQnBsd2FmREpReFEzRzdyME43eWlzWXc?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Signals Confident Growth Beyond CF</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-14T00:05:23+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Vertex veers upwards on impressive results - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMijwFBVV95cUxPcktZWjFMS0t5SjJ2bkxIeHZqRGhtNHAzMzdZeTBaUllQN2FMYXJ0dHI0SG9hMzYtRUdIYjdpeDlFWU9fZTE5MDlyQ09paGREWkQtSnpsT09aeTJOaWVKZXF4eW5LNEpiYUFyNTBoMjVXV2I3WmxNWWwtTE9Xejc3ZXN3TWJ2bHVuWXllNm1mMA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijwFBVV95cUxPcktZWjFMS0t5SjJ2bkxIeHZqRGhtNHAzMzdZeTBaUllQN2FMYXJ0dHI0SG9hMzYtRUdIYjdpeDlFWU9fZTE5MDlyQ09paGREWkQtSnpsT09aeTJOaWVKZXF4eW5LNEpiYUFyNTBoMjVXV2I3WmxNWWwtTE9Xejc3ZXN3TWJ2bHVuWXllNm1mMA?oc=5\" target=\"_blank\">Vertex veers upwards on impressive results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2026-02-14T00:57:16+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPcUFVcGZoOG14VE5Bc281dVRVLVplam0xRUxiTWRsT3JSTFlrNmM4cFFXQkhFVDJJNG1ybWh0d0MwbXAxT2pSSHV5Q0NKNWxrZGVZaVdDWXphLWN3cW1jVVE0XzNUNVFfNXhJLUpaV3FrWjVGZjN5V29fYWRQSm9fOTl6TFdkbjVKMlh0MUdB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxPcUFVcGZoOG14VE5Bc281dVRVLVplam0xRUxiTWRsT3JSTFlrNmM4cFFXQkhFVDJJNG1ybWh0d0MwbXAxT2pSSHV5Q0NKNWxrZGVZaVdDWXphLWN3cW1jVVE0XzNUNVFfNXhJLUpaV3FrWjVGZjN5V29fYWRQSm9fOTl6TFdkbjVKMlh0MUdB?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-02-11T03:03:00+00:00",
      "source": "Yahoo Finance"
    }
  ],
  "product_launches": [
    {
      "title": "Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5\" target=\"_blank\">Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-13T17:02:15+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highligh - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNTmtLdkUxTmFSQ19ieWxlMHp5X1dxdDFpOU1kTXVTcVN2OTJfQjE5aDZkWUdpOV9tWXBmcENfQzhaaDBsWUJ2TGgwVDlpQ1RvZXNxbEVwYUZ1THRVaXA3dXl0WWNVbDMtdjZkbGFvRE9TdnM4YVMtbFZhT0ZnNUdZc3lCOThGZFVjNGZjRGhHM0hkTExJV3dtaDFibC1MSU1IbWsxT3o5Tk15bHlIblU0TXZFQWkwSW4ya2ZQWm53ZWg4Z3Z4YmE2WDBNdVRzVFpoZUZpVV9lRzdXR3dsQUNlVnNjNXg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNTmtLdkUxTmFSQ19ieWxlMHp5X1dxdDFpOU1kTXVTcVN2OTJfQjE5aDZkWUdpOV9tWXBmcENfQzhaaDBsWUJ2TGgwVDlpQ1RvZXNxbEVwYUZ1THRVaXA3dXl0WWNVbDMtdjZkbGFvRE9TdnM4YVMtbFZhT0ZnNUdZc3lCOThGZFVjNGZjRGhHM0hkTExJV3dtaDFibC1MSU1IbWsxT3o5Tk15bHlIblU0TXZFQWkwSW4ya2ZQWm53ZWg4Z3Z4YmE2WDBNdVRzVFpoZUZpVV9lRzdXR3dsQUNlVnNjNXg?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highligh</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-02-13T05:12:17+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance - Intellectia AI",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZ0R1MTM2NDZYSFZLZE9Cc3F4bnBIRlpsb1FUcnV1VWVIUGtzY2xuTXpUN1Brc1hZWTRqVDZEcUtCM3lsZW80VFN0bkRfOUJsdk5mU2pNMWhSVGpYQjVxUmJ3RXp2aG4tVW9rVWNhZDFpQW8yeG5IdE44OEZ4VnlSV0hUTzdxN1FsVU5ES1VsOW8xVncycmpzZUkzb3YzS0NZQzZhY1phMW9Zdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZ0R1MTM2NDZYSFZLZE9Cc3F4bnBIRlpsb1FUcnV1VWVIUGtzY2xuTXpUN1Brc1hZWTRqVDZEcUtCM3lsZW80VFN0bkRfOUJsdk5mU2pNMWhSVGpYQjVxUmJ3RXp2aG4tVW9rVWNhZDFpQW8yeG5IdE44OEZ4VnlSV0hUTzdxN1FsVU5ES1VsOW8xVncycmpzZUkzb3YzS0NZQzZhY1phMW9Zdw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Intellectia AI</font>",
      "published": "2026-02-13T04:09:50+00:00",
      "source": "Intellectia AI"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-02-13",
      "close": 491.4700012207031
    },
    "history": [
      {
        "date": "2026-02-05",
        "close": 458.80999755859375
      },
      {
        "date": "2026-02-06",
        "close": 477.9200134277344
      },
      {
        "date": "2026-02-09",
        "close": 470.8699951171875
      },
      {
        "date": "2026-02-10",
        "close": 463.4800109863281
      },
      {
        "date": "2026-02-11",
        "close": 461.239990234375
      },
      {
        "date": "2026-02-12",
        "close": 465.0199890136719
      },
      {
        "date": "2026-02-13",
        "close": 491.4700012207031
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}